BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8033931)

  • 1. Haematological disturbances during long-term valproate therapy.
    Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
    Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder.
    Fawcett RG
    J Clin Psychiatry; 1997 Mar; 58(3):125. PubMed ID: 9108818
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate use associated with persistent hyperammonemia and mitochondrial injury in a child with Down's syndrome.
    Kane RE; Kotagel S; Bacon BR; Vogler CA
    J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):223-7. PubMed ID: 1534366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in red blood cells with valproate therapy.
    Ozkara C; Dreifuss FE; Apperson Hansen C
    Acta Neurol Scand; 1993 Sep; 88(3):210-2. PubMed ID: 8256557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus associated with use of valproate.
    Asconapé JJ; Manning KR; Lancman ME
    Epilepsia; 1994; 35(1):162-3. PubMed ID: 8112240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary pure red-cell aplasia during valproate monotherapy: clinical observations and spectral electroencephalographic aspects.
    Farkas V; Szabó M; Rényi I; Kohlhéb O; Benninger C
    J Child Neurol; 2000 Jul; 15(7):485-7. PubMed ID: 10921523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocytosis associated with divalproex treatment.
    Tsivkin R; Saito E; Kafantaris V
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1011-4. PubMed ID: 16379522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate and thrombocytopenia.
    Hoffman LM
    Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe hematologic toxicity of valproic acid. A report of four patients.
    Ganick DJ; Sunder T; Finley JL
    Am J Pediatr Hematol Oncol; 1990; 12(1):80-5. PubMed ID: 2106802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient thrombocytopenia in a child on sodium valproate.
    Cole AP
    Dev Med Child Neurol; 1978 Aug; 20(4):487-90. PubMed ID: 357235
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration--with statistical analysis of 33 cases administrated sodium valproate].
    Terui T; Ktda K; Mitani T; Terada S; Kure T; Takamura H; Hirayama M; Niitsu Y; Nakazawa O
    Rinsho Ketsueki; 1987 Jun; 28(6):865-71. PubMed ID: 3118077
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium valproate and thrombocytopenia.
    Miyake S; Honda K; Kimura S; Ike Y
    Brain Dev; 1979; 1(4):319-22. PubMed ID: 121951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.
    Allan RW
    Hematology; 2007 Dec; 12(6):493-6. PubMed ID: 17852444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of thrombocytopenia in psychiatric patients taking valproate.
    Trannel TJ; Ahmed I; Goebert D
    Am J Psychiatry; 2001 Jan; 158(1):128-30. PubMed ID: 11136646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate and thrombocytopenia.
    Winfield DA; Benton P; Espir ML; Arthur LJ
    Br Med J; 1976 Oct; 2(6042):981. PubMed ID: 788857
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematologic manifestations of long-term valproate therapy.
    May RB; Sunder TR
    Epilepsia; 1993; 34(6):1098-101. PubMed ID: 8243362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.